Call out to all our NZ & Australian POISE-3 sites to tune into @twpainter presenting the TxA arm results of the POISE-3 trial shortly! Learn about the implications to patient care & safety! Thank you for your hard work and dedication! #ASM22PER@ANZCA@PHRIresearch@katy_skier
All major surgical procedures do not lead to significant blood risks so need to choose TXA wisely (if bleeding risk is significant enough or microhemostasis is a problem etc.) These risks are multi factorial.
Among patients undergoing noncardiac surgery, the incidence of the composite bleeding outcome was significantly lower with tranexamic acid than with placebo. #ACC22nej.md/3IMTKoz
Among patients undergoing noncardiac surgery, the incidence of the composite bleeding outcome was significantly lower with tranexamic acid than with placebo. #ACC22nej.md/3IMTKoz
Outstanding work. Do you think it could potentially be the vasopressors rather than the volatile dose? Known to reduce cerebral oxygenation…. journals.lww.com/jnsa/Abstra…
A big thank you to the @ctn_anzca@anzca@david__highton who have re-jigged #CTN21 again 😬😅😇 Now a virtual meeting with Brisbane hub. Looking forward to more great RCTs!
Registration & call for abstracts now open for the @ANZCA CTN workshop! Join us in sunny Brisbane for #CTN21 on 5-8 August 2021. Virtual and in-person registration options available. For more info and to register visit the website: bit.ly/3yI4wZr